Buy price
344.56
Amgen (AMGN) Stock Price Today — Live Chart and Analysis
The company is a biotechnology firm that discovers and develops therapeutic treatment solutions in the areas of oncology, hematology, cardiovascular disease and neuroscience.
Sell price
344.29
Market Cap
119.33 B
Amgen chart
Price Performance
1 week
+0.84% +0.84%
+0.84% +0.84%
1 month
-0.19% -0.19%
-0.19% -0.19%
YTD
-14.99% -14.99%
-14.99% -14.99%
Year
+5.66% +5.66%
+5.66% +5.66%
5 years
+89.46% +89.46%
+89.46% +89.46%
Information regarding past performance is not a reliable indicator of future performance.
Amgen AMGN Profile
- Sector Health Care
- Industry Biotechnology
- Country United States
- Founded 1980
- ISIN US0311621009
- CEO Robert A. Bradway
- amgen.com
Analysis
The company’s stock has out-performed the broader market so far in 2025, while the company managed to beat EPS consensus estimates during the last quarter results. The company's pipeline seems to be promising and the company expects positive results from its candidates this year. Moreover, the FDA approval for Parsabiv which is a drug for hemodialysis is actually the first new treatment in more than 10 years. Going forward, strong competition and pipeline setbacks remain the company’s most significant headwinds.
How can I buy Amgen?
- 1
Sign up
Create an account and complete a quick verification.
- 2
Deposit funds
Add money to your wallet via card, bank transfer, or crypto.
- 3
Trade
Choose AMGN, set the amount, and click buy or sell — that’s it!
Amgen
AMGN
344.425
-1.19%
Instrument CFD
FAQ